Cairo – Mubasher: The Ordinary General Assembly of Cairo Pharmaceuticals and Chemical Industries has approved the Board of Directors' report on the company's activities and its financial statements for the fiscal year ended June 30, 2026.
According to the company's disclosure to the Egyptian Exchange (EGX) today, the General Assembly approved the distribution of cash dividends to shareholders in the form of a cash coupon of EGP 22 per share for the fiscal year ended June 30, 2026.
It also decided to distribute profit-sharing to employees equivalent to 12 months of basic wages (corresponding to the total annual basic wages of the company's employees during the fiscal year 2025-2026).
Furthermore, it was decided to discharge and release the Board of Directors from liability for the fiscal year ended June 30, 2026.
